Featured Research

from universities, journals, and other organizations

New Pathways Link Liver Disease To Changes In The Central Nervous System

Date:
January 6, 2006
Source:
John Wiley & Sons, Inc.
Summary:
In a new study, researchers speculated that cholestatic liver damage may be associated with an immune response affecting the central nervous system, specifically the brain, which could represent a novel and potentially important pathway.

Liver disease is often associated with "sickness behaviors," such as malaise, listlessness, anorexia, difficulty concentrating, and fatigue. In cholestatic liver diseases (where bile production is impaired) such as primary biliary cirrhosis, fatigue occurs in up to 86 percent of patients. Previous studies have suggested that these symptoms originate from changes to the central nervous system (CNS), but little is understood about how these changes occur or the pathways involved.

In a study led by Steven M. Kerfoot of the Immunology Research Group at the University of Calgary in Canada and published in the January 2006 issue of Hepatology, researchers speculated that cholestatic liver damage may be associated with an immune response affecting the central nervous system, specifically the brain, which could represent a novel and potentially important pathway.

Hepatology, the official journal of the American Association for the Study of Liver Diseases (AASLD), published by John Wiley & Sons, Inc. is available online via Wiley InterScience at http://www.interscience.wiley.com/journal/hepatology.

The study involved creating cholestasis in mice by tying off the bile duct. Cerebral endothelial cells (cells lining the blood vessels of the brain) were then isolated and examined to see if they were activated, as activated endothelium tends to interact with activated immune cells. In addition, researchers analyzed TNF-alpha (a messenger protein involved in inflammation) production by monocytes, a type of white blood cell, to determine if a peripheral immune response was present.

The results showed an increase in TNF-alpha production by monocytes and activated endothelial cells in the cholestatic mice versus the control mice. The authors suggest that cholestasis is also associated with a broad activation of other immune cells within the central nervous system that produce TNF-alpha. "Given the significant behavioral effects of TNF-alpha within the CNS (i.e. sickness behaviors), the production of TNF-alpha within the brains of cholestatic mice is likely to be important in the alterations in behavior, as well as in the changes in the neurotransmitter systems which sub-serve these behaviors within the brains of cholestatic mice and may have direct implications for these systems in cholestatic patients," the authors conclude.

In an accompanying editorial in the same issue, Alexander I. Aspinall and David H. Adams of the Institute for Biomedical Research at the University of Birmingham in England, note the difficulties in treating fatigue associated with liver disease and the lack of understanding of the mechanisms that cause it, adding that the University of Calgary study "provides a novel mechanism to link cholestasis, inflammation and sickness behavior and is potentially important in understanding this poorly characterized aspect of chronic cholestasis." They state that the fact that monocytes were found in similar locations to those seen in inflammatory brain disease supports the likelihood that they are linked to pathological effects. However, they note that there are still unresolved issues in understanding sickness behaviors and that it remains unknown whether the results from the animal study will translate to cholestasis in humans. One key message from the study is that a number of factors most likely affect the CNS leading to sickness behaviors.

"Identifying the mediators involved is important not only to complete our understanding of the pathogenesis of sickness behaviors but also to inform the development of appropriate therapeutic agents," the authors state, adding that the risks of anti-TNF-alpha therapy most likely outweigh the potential benefits. They conclude: "It is to be hoped that a better understanding of these processes may lead to the development of more effective and rational therapies for this disabling symptom of cholestatic liver disease."

###

Article: "TNF-alpha-Secreting Monocytes Are Recruited Into the Brain of Cholestatic Mice," Steven M. Kerfoot, Charlotte D'Mello, Henry Nguyen, Maureen N. Ajuebor, Paul Kubes, Tai Le, Mark G. Swain, Hepatology, January 2006 (DOI: 10.1002/hep.21003).

Editorial: "Sickness Behaviors in Chronic Cholestasis: An Immune-mediated Process?" Alexander I. Aspinall, David H. Adams, Hepatology, January 2006 (DOI: 10.1002/hep.21032)


Story Source:

The above story is based on materials provided by John Wiley & Sons, Inc.. Note: Materials may be edited for content and length.


Cite This Page:

John Wiley & Sons, Inc.. "New Pathways Link Liver Disease To Changes In The Central Nervous System." ScienceDaily. ScienceDaily, 6 January 2006. <www.sciencedaily.com/releases/2006/01/060106004614.htm>.
John Wiley & Sons, Inc.. (2006, January 6). New Pathways Link Liver Disease To Changes In The Central Nervous System. ScienceDaily. Retrieved April 25, 2014 from www.sciencedaily.com/releases/2006/01/060106004614.htm
John Wiley & Sons, Inc.. "New Pathways Link Liver Disease To Changes In The Central Nervous System." ScienceDaily. www.sciencedaily.com/releases/2006/01/060106004614.htm (accessed April 25, 2014).

Share This



More Health & Medicine News

Friday, April 25, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Deadly Fungus Killing Bats, Spreading in US

Deadly Fungus Killing Bats, Spreading in US

AP (Apr. 24, 2014) A disease that has killed more than six million cave-dwelling bats in the United States is on the move and wildlife biologists are worried. White Nose Syndrome, discovered in New York in 2006, has now spread to 25 states. (April 24) Video provided by AP
Powered by NewsLook.com
Companies Ramp Up Wellness to Lower Health Costs

Companies Ramp Up Wellness to Lower Health Costs

AP (Apr. 24, 2014) That little voice telling you to exercise, get in shape and get healthy is probably coming from your boss. More companies are beefing up wellness programs to try and cut down their health care costs. (April 24) Video provided by AP
Powered by NewsLook.com
Blood From World's Oldest Woman Suggests Life Limit

Blood From World's Oldest Woman Suggests Life Limit

Newsy (Apr. 24, 2014) Scientists say for the extremely elderly, their stem cells might reach a state of exhaustion. This could limit one's life span. Video provided by Newsy
Powered by NewsLook.com
FDA Wants To Ban Sales Of E-Cigarettes To Minors

FDA Wants To Ban Sales Of E-Cigarettes To Minors

Newsy (Apr. 24, 2014) The Food and Drug Administration wants to crack down on the use of e-cigarettes, banning the sale of the product to minors. Video provided by Newsy
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins